Position in CBLL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$13,871,245
+$2,906,245 QoQ
Shares Held
756,751
+51.4% QoQ
Ownership
1.99%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CBLL Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $794,156,024 across 13 Medical Devices names. CBLL ranks #8 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
4,633,237 | $290,735,621 | |
| 2 | ABT |
Abbott Laboratories
|
1,707,764 | $175,336,129 | |
| 3 | DXCM |
Dexcom Inc
|
1,666,408 | $104,650,422 | |
| 4 | MDT |
Medtronic plc
|
989,189 | $85,713,226 | |
| 5 | PEN |
Penumbra Inc
|
135,000 | $44,329,950 | |
| 6 | EW |
Edwards Lifesciences Corp
|
501,866 | $40,189,429 | |
| 7 | STE |
STERIS plc
|
87,486 | $19,345,779 | |
| 8 | CBLL |
Ceribell, Inc.
This page
|
756,751 | $13,871,245 |
All Filings in CBLL
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,871,245 | 756,751 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,965,000 | 500,000 | Shares | Sole | 2026-02-17 | |
| 2024-12-31 | $8,231,703 | 318,072 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||